Lista de obras - Fekade Bruck Sime - Dominio Público Uruguay

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration

scientific article published on 20 December 2019

A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration

scientific article published on 19 July 2018

A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study

artículo científico publicado en 2019

Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies

artículo científico publicado en 2015

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy

artículo científico publicado en 2014

An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units

artículo científico publicado en 2014

Antibiotic Dosing In Critically Ill Patients Receiving Renal Replacement Therapy

artículo científico publicado en 2016

Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization

artículo científico

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

artículo científico publicado en 2015

Cerebrospinal fluid penetration of ceftolozane/tazobactam in critically ill patients with an indwelling external ventricular drain

artículo científico publicado en 2020

Challenges in Antifungal Therapy in Diabetes Mellitus

artículo científico publicado en 2020

Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

scientific article published on 24 September 2018

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime

artículo científico publicado en 2020

Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.

artículo científico publicado en 2018

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

artículo científico publicado en 2012

Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured review

artículo científico publicado en 2017

Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing Escherichia coli in South Asia

artículo científico publicado en 2021

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

artículo científico publicado en 2014

How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients

artículo científico publicado en 2018

Individualising Therapy to Minimize Bacterial Multidrug Resistance

artículo científico publicado en 2018

Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review

scientific article published on 23 November 2018

Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation

article

Optimization of dosing regimens and dosing in special populations.

artículo científico

Optimizing dosing of antibiotics in critically ill patients

artículo científico

Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates

artículo científico publicado en 2022

Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase (ESBL)-producing versus non-ESBL-producing Escherichia coli in a hollow-fibre infection model

artículo científico publicado en 2022

Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model

artículo científico publicado en 2022

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy

artículo científico publicado en 2016

Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model

artículo científico publicado en 2022

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

artículo científico publicado en 2018

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction

scientific article published on 23 September 2019

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

scientific article published on 06 June 2019

Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies

artículo científico publicado en 2014

Solid nanoparticles for oral antimicrobial drug delivery: a review

artículo científico publicado en 2019

The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis

scientific article published on 30 September 2019

Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia

artículo científico

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

artículo científico publicado en 2019

What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review

scientific article published on 01 November 2019

β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis

scientific article published on 05 November 2019

Lista de obras de Fekade Bruck Sime

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration

A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration

A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic study

Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy

An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units

Antibiotic Dosing In Critically Ill Patients Receiving Renal Replacement Therapy

Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

Cerebrospinal fluid penetration of ceftolozane/tazobactam in critically ill patients with an indwelling external ventricular drain

Challenges in Antifungal Therapy in Diabetes Mellitus

Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime

Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured review

Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing <i>Escherichia coli</i> in South Asia

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients

Individualising Therapy to Minimize Bacterial Multidrug Resistance

Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review

Multidrug-resistant Acinetobacter baumannii infections: Current evidence on treatment options and the role of pharmacokinetics/pharmacodynamics in dose optimisation

Optimization of dosing regimens and dosing in special populations.

Optimizing dosing of antibiotics in critically ill patients

Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against <i>Escherichia coli</i> clinical isolates

Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase (ESBL)-producing versus non-ESBL-producing Escherichia coli in a hollow-fibre infection model

Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing <i>Escherichia coli</i> clinical isolates in a hollow-fibre infection model

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy

Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies

Solid nanoparticles for oral antimicrobial drug delivery: a review

The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis

Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review

β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis